![Tae Gyu Kim](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 3 M $ al 30/06/2026
Tae Gyu Kim holds the position of Director, Head-Research & Development at ViGenCell, Inc. Mr. Kim also serves as a Professor at the Catholic University of Korea.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
VIGENCELL, INC. 3,9 % | 08/12/2025 | 800.000 ( 3,9 % ) | 3 M $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| VIGENCELL INC. | Director Técnico/Científico/I+D | - |
Catholic University of Korea
 Catholic University of Korea Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 2 |
|---|---|
Catholic University of Korea
Catholic University of Korea Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ViGenCell, Inc.
 ViGenCell, Inc. BiotechnologyHealth Technology Develops immune cell therapy | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
Elige MarketScreener 
